INGN 201 (Ad5CMV-p53): Completed Phase III trial review

Introgen Therapeutics Inc., Austin, Texas
Product: INGN 201 (Ad5CMV-p53)

Read the full 94 word article

How to gain access

Continue reading with a
two-week free trial.